This title appears in the Scientific Report :
2001
Please use the identifier:
http://hdl.handle.net/2128/117 in citations.
Chemoenzymatische Synthese optisch aktiver $\beta,\delta$-Dihydroxyester
Chemoenzymatische Synthese optisch aktiver $\beta,\delta$-Dihydroxyester
A new access to optically active $\beta, \delta$-dihydroxy esters and $\delta$-hydroxy-$\beta$-keto esters is presented. These compunds are valuable intermediates for the synthesis of important natural products and pharmaceuticals, e. g. HMG-CoA reductase inhibitors of the mevinic acid type. The syn...
Saved in:
Personal Name(s): | Wolberg, Michael (Corresponding author) |
---|---|
Contributing Institute: |
Biotechnologie 2; IBT-2 |
Imprint: |
Jülich
Forschungszentrum Jülich GmbH Zenralbibliothek, Verlag
2002
|
Physical Description: |
138 p. |
Dissertation Note: |
Oldenburg, Univ., Diss., 2001 |
Document Type: |
Book Dissertation / PhD Thesis |
Research Program: |
Verfahrenstechnik zur mikrobiellen Gewinnung von Primärmetaboliten |
Series Title: |
Berichte des Forschungszentrums Jülich
3988 |
Subject (ZB): | |
Link: |
OpenAccess |
Publikationsportal JuSER |
LEADER | 05780nam a2200517 a 4500 | ||
---|---|---|---|
001 | 33330 | ||
005 | 20200610184342.0 | ||
980 | |a VDB | ||
980 | |a JUWEL | ||
980 | |a ConvertedRecord | ||
980 | |a phd | ||
980 | |a I:(DE-Juel1)IBG-1-20101118 | ||
980 | |a UNRESTRICTED | ||
980 | |a FullTexts | ||
980 | 1 | |a FullTexts | |
490 | 0 | |0 PERI:(DE-600)2414853-2 |8 4710 |a Berichte des Forschungszentrums Jülich |v 3988 |x 0944-2952 | |
037 | |a PreJuSER-33330 | ||
088 | 1 | |a Juel-3988 | |
088 | |a Juel-3988 |2 JUEL | ||
856 | 4 | |u http://juser.fz-juelich.de/record/33330/files/Juel_3988_Wolberg.pdf |y OpenAccess | |
970 | |a VDB:(DE-Juel1)3811 | ||
655 | 7 | |a Hochschulschrift |x Dissertation (Univ.) | |
520 | |a A new access to optically active $\beta, \delta$-dihydroxy esters and $\delta$-hydroxy-$\beta$-keto esters is presented. These compunds are valuable intermediates for the synthesis of important natural products and pharmaceuticals, e. g. HMG-CoA reductase inhibitors of the mevinic acid type. The synthesis strategy is based on an unprecedented highly regio- and enantioselective biocatalytic reduction of achiral $\beta, \delta$-diketo esters. In a screening, two enantiocomplementary biocatalysts were found to be particularly suitable for this purpose. Thus, the $\beta, \delta$-diketo ester $\textit{tert}$-butyl 6-chloro-3,5-dioxohexanoate was reduced by NADP(H)-dependent alcohol dehydrogenase of $\textit{Lactobacillus brevis}$ to afford enantiomerically pure $\delta$-hydroxy-$\beta$-keto ester $\textit{tert}$-butyl (S)-6-chloro-5-hydroxy-3-oxohexanoate in a 72-84 % isolated yield (>99.5% ee). The enzyme is readily available in the form of a crude cell extract from a recombinant $\textit{E. coli}$ strain (recLBADH). A scale-up of the one-step substrate synthesis (140 g scale) and of the enzymatic reduction (70 g scale, substrate-coupled NADPH-regeneration) was established. The enantiomeric $\delta$-hydroxy-$\beta$-keto ester $\textit{tert}$-butyl (R)-6-chloro-5-hydroxy-3-oxohexanoate was obtained by reduction of $\textit{tert}$-butyl 6-chloro-3,5-dioxohexanoate with baker's yeast ($\textit{Saccharomyces cerevisiae}$). A detailed investigation of the reaction parameters of this whole-cell transformation led to the application of a biphasic system by which the enantiomeric excess could be raised from 48% ee to 94% ee (50% isolated yield). The $\beta$-keto group of both enantiomers thus obtained was reduced by $\textit{syn}$- and $\textit{anti}$-selective borohydride reductions. Combination of the reduction methods afforded all four stereoisomers of the crystalline $\beta, \delta$-dihydroxy ester $\textit{tert}$-butyl 6-chloro-3,5-dihydroxyhexanoate (>99% ee and $\textit{dr}$ > 200:1 each, 52-70% isolated yield). Alternatively, the $\textit{syn}$- (3R,5S)-isomer of this known building block was obtained in one step and with high stereoisomeric purity by reduction of $\textit{tert}$-butyl 6-chloro-3,5-dioxohexanoate with whole cells of $\textit{Lactobacillus kefir}$. An iodide and an epoxide suitable for C-C-bond formation at C-6 were derived from $\textit{tert}$-butyl $\textit{syn}$-(3R,5S)-6-chloro-3,5-dihydroxyhexanoate. recLBADH accepts a variety of $\beta, \delta$-diketo esters as was determined in a photometric assay. The $\beta, \delta$-diketo esters $\textit{tert}$-butyl 3,5-dioxohexanoate and $\textit{tert}$-butyl 3,5-dioxoheptanoate were reduced an a 1-10 mmol scale to afford the corresponding (R)-$\delta$-hydroxy-$beta$-keto esters with 99.4% ee and 98.1% ee, respectively (61-77 % isolated yield). The reduction ofthe branched $\beta, \delta$-diketo ester $\textit{tert}$-butyl $\textit{rac}$-4-methyl-3,5-dioxohexanoate proceeds via a dynamic kinetic resolution which resulted in a 66% isolated yield of the corresponding $\textit{syn}$-(4S,5R)-$\delta$-hydroxy-$beta$-keto ester (99.2% ee, dr = 35:1). To underline the applicability of the virtually enantiopure enzymatic products, they were used as starting materials for several new natural product syntheses. Furthermore, a convenient process for the large-scale separation of noncrystallising diastereomeric $\textit{syn}$- and $\textit{anti}$- 1,3-diols was developed. The crucial step of this new method is a diastereomer-differentiating hydrolysis of the respective acetonides. | ||
915 | |0 StatID:(DE-HGF)0510 |2 StatID |a OpenAccess | ||
914 | 1 | |y 2001 | |
502 | |a Oldenburg, Univ., Diss., 2001 |b Dr. (Univ.) |c Univ. Oldenburg |d 2001 | ||
913 | 1 | |0 G:(DE-Juel1)FUEK93 |b Lebenswissenschaften |k 41.40.0 |l Biotechnologie |v Verfahrenstechnik zur mikrobiellen Gewinnung von Primärmetaboliten |x 0 | |
300 | |a 138 p. | ||
245 | |a Chemoenzymatische Synthese optisch aktiver $\beta,\delta$-Dihydroxyester | ||
024 | 7 | |2 Handle |a 2128/117 | |
024 | 7 | |2 URI |a 117 | |
260 | |a Jülich |b Forschungszentrum Jülich GmbH Zenralbibliothek, Verlag |c 2002 | ||
100 | 1 | |0 P:(DE-Juel1)VDB1800 |a Wolberg, Michael |b 0 |e Corresponding author |u FZJ | |
909 | C | O | |o oai:juser.fz-juelich.de:33330 |p openaire |p open_access |p driver |p VDB |p dnbdelivery |
500 | |a Record converted from VDB: 12.11.2012 | ||
536 | |a Verfahrenstechnik zur mikrobiellen Gewinnung von Primärmetaboliten |0 G:(DE-Juel1)FUEK93 |2 G:(DE-HGF) |c 41.40.0 |x 0 | ||
336 | |2 DRIVER |a doctoralThesis | ||
336 | |a PSP 2.9.2 Magnets |0 2 |2 EndNote | ||
336 | |a Book |0 PUB:(DE-HGF)3 |2 PUB:(DE-HGF) | ||
336 | |a Dissertation / PhD Thesis |0 PUB:(DE-HGF)11 |2 PUB:(DE-HGF) | ||
336 | |2 ORCID |a DISSERTATION | ||
336 | |2 DataCite |a Output Types/Dissertation | ||
336 | |2 BibTeX |a PHDTHESIS | ||
981 | |a I:(DE-Juel1)IBG-1-20101118 | ||
920 | |k Biotechnologie 2; IBT-2 |0 I:(DE-Juel1)VDB56 |g IBT |l Biotechnologie 2 |x 0 |z ab 31.10.10 weitergeführt IBG-1 | ||
990 | |a Wolberg, M. |0 P:(DE-Juel1)VDB1800 |b 0 |e Corresponding author |u FZJ |